Management Consulting

Commercial Strategy and Go-to-Market Model

In-depth market intelligence for your business

With a full team of global specialists, you’ll get a granular view of market intelligence, research and trends. Receive in-depth, actionable insights on all areas of your business, including revenue, sales volume, product mix, supply chain, distribution channels, R&D, and manufacturing.

Tailored strategy, planning, and execution

The successful realization of commercial potential requires the combination of a precise strategy with a robust go-to-market model. At Alira Health, our team of global specialists designs both specifically for your business.

From the beginning, we’ll help you define strategic goals, identify critical success factors needed to achieve those goals, and plan the commercial and scientific actions to realize them.

We’ll help you determine which organizational capabilities will be critical to your success, and insight on whether those should be developed internally or accessed through third-party partnerships. Our extensive, world-wide network of healthcare, pharma, and MedTech organizations helps us connect you with the right partners.

Why choose Alira Health?

With Alira Health as your partner, you will benefit from:

  • Market-leading and global specialists with diverse industry and advisory experience
  • Our nuanced understanding of both the customer and competitive space to deliver strategic guidance and go-to-market model development

Related news

Events January 27, 2023
Alira Health and Biocat Startup Support Program Presentation
Biocat and Alira Health partnered to foster Market Access for startups. Alira Health, a global healthcare advisory and technology company, and Biocat, a strategic stakeholder building(...)
Market Access Startups
Publications January 20, 2023
Insights on Market Access
To get her perspective on market access and what to expect in 2023, we spoke with Nerea Blanqué, Senior Vice President of Market Access and Pricing at Alira Health.
Market Access Medical Devices Pharma
Publications December 21, 2022
2022 Recap: Your Favorite Alira Health Publications
In 2022, the Alira Health team of scientists, strategists, economists, clinicians, and biostatisticians shared actionable insights, industry thought leadership, and leading-edge guidance(...)
Clinical Digital Health Market Access MedTech Pharma Regulatory
News November 15, 2022
Alira Health Partners with Policy Matters to Foster Market Access in the UK
Alira Health, a global advisory and clinical research firm whose mission is to humanize healthcare and life sciences, announces its partnership with leading UK market access specialist(...)
Digital Health Healthcare Consulting Market Access
News November 10, 2022
Alira Health and GDMH together to boost Life Sciences innovation
The companies join forces for collaborative research and co-development of projects in the fields of Digital Health, Real-World Evidence and Market Access.
Clinical Trials Digital Health DTx Market Access Real-World Evidence RWE
Events October 7, 2022
Debate Sobre los IPT en Oncología
We are pleased to announce our next event, “Debate Sobre los IPT en Oncología,” focusing on price and reimbursement (P&R) of vital oncology and oncohematology therapies.
Market Access Product Development Regulatory
Publications October 5, 2022
Relative Weight of the Variables Evaluated Through the Therapeutic Positioning Reports in the Pricing and Reimbursement of Oncological and Oncohematology Medicines in Spain
Discover how companies’ target prices are impacted by the different variables leveraged during the P&R process for oncology and oncohematology’s first indication.
Market Access Oncology Spain
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.